Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 2
2013 3
2014 5
2015 6
2016 14
2017 4
2018 6
2019 8
2020 10
2021 21
2022 30
2023 24
2024 29
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Subcutaneous versus intravenous nivolumab for renal cell carcinoma.
Albiges L, Bourlon MT, Chacón M, Cutuli HJ, Chuken YAL, Żurawski B, Mota JM, Magri I, Burotto M, Luz M, de Menezes J, Ruiz EPY, Fu S, Richardet M, Valderrama BP, Maruzzo M, Bracarda S, Breckenridge M, Vezina HE, Rathod D, Yu Z, Zhao Y, Dixon M, Perumal D, George S. Albiges L, et al. Among authors: maruzzo m. Ann Oncol. 2025 Jan;36(1):99-107. doi: 10.1016/j.annonc.2024.09.002. Epub 2024 Sep 15. Ann Oncol. 2025. PMID: 39288844 Free article. Clinical Trial.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
Choueiri TK, Powles T, Albiges L, Burotto M, Szczylik C, Zurawski B, Yanez Ruiz E, Maruzzo M, Suarez Zaizar A, Fein LE, Schutz FA, Heng DYC, Wang F, Mataveli F, Chang YL, van Kooten Losio M, Suarez C, Motzer RJ; COSMIC-313 Investigators. Choueiri TK, et al. Among authors: maruzzo m. N Engl J Med. 2023 May 11;388(19):1767-1778. doi: 10.1056/NEJMoa2212851. N Engl J Med. 2023. PMID: 37163623 Free PMC article. Clinical Trial.
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group.
Toss A, Piombino C, Quarello P, Trama A, Mascarin M, Lambertini M, Canesi M, Incorvaia L, Milano GM, Maruzzo M, Perrone F, Peccatori F, Ferrari A. Toss A, et al. Among authors: maruzzo m. Eur J Cancer. 2024 Nov;212:115042. doi: 10.1016/j.ejca.2024.115042. Epub 2024 Sep 26. Eur J Cancer. 2024. PMID: 39362174 Free article. Review.
From walls to wonder: Talking about spaces tailored for adolescents and young adults with cancer.
Clerici CA, Scotti F, Pagani Bagliacca E, Rossi S, Patriccioli A, Quarello P, Toss A, Mascarin M, Maruzzo M, Lambertini M, Incorvaia L, Milano GM, Zucchetti G, Tornesello A, Spinelli M, Puccini A, Bertuzzi AF, Indini A, Perillo T, Baldi GG, Razzaboni E, Colombo C, Marziali L, Massimino M, Peccatori FA, Ferrari A. Clerici CA, et al. Among authors: maruzzo m. Tumori. 2025 Jun;111(3):194-199. doi: 10.1177/03008916251330771. Epub 2025 Apr 15. Tumori. 2025. PMID: 40231336
Second medical opinion in oncological setting.
Maruzzo M, La Verde N, Russo A, Marchetti P, Scagnoli S, Gonzato O, Di Maio M, Zagonel V, Galvano A, Lanzetta G, Perrone F, Beretta G, Bordonaro R, Comandone A, Cinieri S, Nicolis F, Gori S. Maruzzo M, et al. Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3. Crit Rev Oncol Hematol. 2021. PMID: 33675905 Free article. Review.
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With FGFR RNA-Overexpressing Urothelial Cancer: The FORT-2 Phase 1b Nonrandomized Clinical Trial.
Sweis RF, Gajate P, Morales-Barrera R, Lee JL, Necchi A, de Braud F, Penel N, Grünwald V, Maruzzo M, Meran J, Ishida TC, Bao W, Zhou Y, Ellinghaus P, Rosenberg JE. Sweis RF, et al. Among authors: maruzzo m. JAMA Oncol. 2024 Nov;10(11):1565-1570. doi: 10.1001/jamaoncol.2024.3900. Epub 2024 Sep 19. JAMA Oncol. 2024. PMID: 39298147 Free PMC article. Clinical Trial.
Malignant hypercalcemia.
Basso U, Maruzzo M, Roma A, Camozzi V, Luisetto G, Lumachi F. Basso U, et al. Among authors: maruzzo m. Curr Med Chem. 2011;18(23):3462-7. doi: 10.2174/092986711796642490. Curr Med Chem. 2011. PMID: 21756237
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
El Zarif T, Nassar AH, Pond GR, Zhuang TZ, Master V, Nazha B, Niglio S, Simon N, Hahn AW, Pettaway CA, Tu SM, Abdel-Wahab N, Velev M, Flippot R, Buti S, Maruzzo M, Mittra A, Gheeya J, Yang Y, Rodriguez PA, Castellano D, de Velasco G, Roviello G, Antonuzzo L, McKay RR, Vincenzi B, Cortellini A, Hui G, Drakaki A, Glover M, Khaki AR, El-Am E, Adra N, Mouhieddine TH, Patel V, Piedra A, Gernone A, Davis NB, Matthews H, Harrison MR, Kanesvaran R, Giudice GC, Barata P, Farolfi A, Lee JL, Milowsky MI, Stahlfeld C, Appleman L, Kim JW, Freeman D, Choueiri TK, Spiess PE, Necchi A, Apolo AB, Sonpavde GP. El Zarif T, et al. Among authors: maruzzo m. J Natl Cancer Inst. 2023 Dec 6;115(12):1605-1615. doi: 10.1093/jnci/djad155. J Natl Cancer Inst. 2023. PMID: 37563779 Free PMC article.
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S. Guida A, et al. Among authors: maruzzo m. Clin Genitourin Cancer. 2024 Dec;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Epub 2024 Sep 14. Clin Genitourin Cancer. 2024. PMID: 39405768
151 results